Company Overview

Mardil Medical, headquartered in Minneapolis, MN, is a venture-backed medical device company developing therapies for structural heart diseases including abnormalities in the shape of the heart muscle or valves. Mardil Medical’s first product, the VenTouch™ Targeted Ventricular Reshaping System, addresses the root cause of Functional Mitral Regurgitation – enlargement of one of the heart’s pumping chambers. The VenTouch System is a conforming jacket that surrounds the heart’s pumping chambers and normalizes their shape with an innovative anatomy correcting adjustability feature. VenTouch™ implantation is designed to minimize patient risk by eliminating the need for open-chest or open-heart surgery, vascular access, stopping of the heart or use of cardio-pulmonary bypass and does not require device or component implantation within the patient’s heart or vessels. Visit www.mardil.com for more information.